Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Encompass Health stock (EHC) sits at $121.63, up 0.29% today. The business is worth $12.00B in the market, good for #789 of 800 on our coverage list.
The stock's 52-week band runs $92.25 to $127.28, and the latest print sits 4.4% under the top end of it.
The stock changes hands at 19.8 times trailing earnings.
10 analysts follow the stock and the average call is "buy". The mean target, $146.78, sits 20.7% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper on P/E than most of BeStock’s coverage scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
10 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
EHC is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $146.78, 20.7% above today’s price, with a consensus rating of Buy.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 12:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$121.63 is the latest print for EHC, a move of +0.29% against yesterday's close of $121.28. Today's low and high so far: $120.74 and $122.90.
Equity value comes to $12.00B at the current price. By that measure it is number 789 of the 800 names in our coverage.
Buyers pay 19.8 times the last twelve months of profit (EPS $5.54).
The year's floor is $92.25 and the ceiling $127.28. Shares are 4.4% away from that ceiling.
It does. Payouts over the past twelve months work out to a 0.62% yield; the latest ex-dividend date was October 1, 2026.
Of 10 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $146.78, with the most cautious at $140.00 and the most optimistic at $155.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on EHC.